MetLife (MET) analyst forecast and price target
Analyst forecast
Consensus of 22 analyst ratings
Based on 9 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| JP Morgan | Maintained | Overweight | $110.00 from $108.00 | Oct 15, 2026 |
| Wells Fargo | Maintained | Overweight | $110.00 from $109.00 | Oct 12, 2026 |
| Barclays | Maintained | Overweight | $111.00 from $97.00 | Oct 7, 2026 |
| Mizuho | Maintained | Outperform | $109.00 from $112.00 | Oct 7, 2026 |
| UBS | Maintained | Buy | $110.00 from $105.00 | Oct 6, 2026 |
| TD Cowen | Maintained | Buy | $110.00 from $105.00 | Oct 5, 2026 |
| Piper Sandler | Upgraded | Neutral → Overweight | $110.00 from $99.00 | Sep 22, 2026 |
| Morgan Stanley | Maintained | Overweight | $111.00 from $103.00 | Aug 24, 2026 |
| Wells Fargo | Maintained | Overweight | $109.00 from $101.00 | Aug 19, 2026 |
| Keefe, Bruyette & Woods | Maintained | Outperform | $108.00 from $105.00 | Aug 11, 2026 |
| JP Morgan | Maintained | Overweight | $108.00 from $106.00 | Aug 11, 2026 |
| Barclays | Maintained | Overweight | $97.00 from $94.00 | Aug 6, 2026 |
| TD Cowen | Maintained | Buy | $105.00 from $87.00 | Jul 22, 2026 |
| JP Morgan | Maintained | Overweight | $106.00 from $96.00 | Jul 21, 2026 |
| Keefe, Bruyette & Woods | Maintained | Outperform | $105.00 from $98.00 | Jul 13, 2026 |
| Evercore ISI Group | Maintained | In-Line | $103.00 from $96.00 | Jul 13, 2026 |
| Jefferies | Maintained | Buy | $103.00 from $97.00 | Jul 10, 2026 |
| Mizuho | Maintained | Outperform | $102.00 from $95.00 | Jul 9, 2026 |
| Wells Fargo | Maintained | Overweight | $101.00 from $95.00 | Jul 9, 2026 |
| UBS | Maintained | Buy | $105.00 from $102.00 | Jul 8, 2026 |
Frequently asked questions
What is the price target for MET stock?
The average 12-month analyst price target for MetLife (MET) is $109.89, with a high estimate of $111.00 and a low of $108.00, across 9 analysts.
Is MET a buy, sell, or hold?
Analysts covering MetLife currently average a Buy rating: 15 buy, 6 hold and 1 sell, from 22 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for MET?
The average price target of $109.89 implies 10.71% upside from the last price of $99.26.
What is the latest analyst rating on MET?
On Oct 15, 2026, JP Morgan maintained MetLife at Overweight with a price target of $110.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.